tradingkey.logo
tradingkey.logo
Search

Coherus BioSciences Inc

CHRS
Add to Watchlist
1.415USD
-0.015-1.05%
Market hours ETQuotes delayed by 15 min
218.22MMarket Cap
0.86P/E TTM

CHRS Financials

See Coherus BioSciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Coherus BioSciences Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.28/-0.27
Revenue / Forecast
12.31M/14.34M
Period
FY2025 Earnings
Revenue(YoY)
42.17M
59.81%
EPS(YoY)
1.43
476.39%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
42.45%-0.28
28.82%-0.31
-227.58%-0.31
2379.61%2.57
-153.51%-0.49
38.34%-0.44
76.99%-0.09
77.09%-0.11
195.51%0.91
5.67%-0.71
---0.41
---0.49
---0.96
---0.76
----
----
----
----
----
----
Revenue
61.99%12.31M
-76.46%12.75M
-83.65%11.57M
-84.22%10.25M
229.25%7.60M
-40.84%54.14M
-5.09%70.77M
10.67%64.98M
-92.88%2.31M
101.81%91.52M
64.16%74.57M
-2.39%58.72M
-46.04%32.44M
-38.19%45.35M
-44.94%45.42M
-31.37%60.15M
-27.60%60.12M
-33.55%73.37M
-27.34%82.50M
-35.40%87.64M
Net Profit
32.25%-38.33M
25.75%-37.64M
-230.49%-35.53M
2404.52%297.77M
-154.99%-56.57M
36.35%-50.70M
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
44.44%-96.08M
-571.00%-45.73M
-237.93%-38.53M
-150.65%-29.90M
Net Margin
51.90%-300.04%
-288.29%-363.56%
-2432.68%-384.73%
17.88%-437.51%
78.84%-623.74%
-7.59%-93.63%
71.43%-15.19%
-629.67%-532.74%
-1162.61%-2947.83%
32.95%-87.03%
---53.16%
---73.01%
---233.47%
---129.81%
----
----
----
----
----
----
Gross Margin
6.04%69.02%
82.21%68.27%
-4.03%67.84%
-18.85%66.89%
72.87%65.09%
392.90%37.47%
25.92%70.69%
42.91%82.43%
-21.52%37.65%
-88.93%7.60%
--56.14%
--57.68%
--47.98%
--68.68%
----
----
----
----
----
----
Debt to assets ratio
-75.63%19.37%
-69.80%19.77%
-83.19%9.79%
-73.79%11.37%
27.85%79.48%
-13.11%65.47%
-28.08%58.24%
-56.86%43.38%
-46.95%62.17%
-23.50%75.36%
--80.98%
--100.55%
--117.19%
--98.51%
----
----
----
----
----
----
Revenue
61.99%12.31M
-76.46%12.75M
-83.65%11.57M
-84.22%10.25M
229.25%7.60M
-40.84%54.14M
-5.09%70.77M
10.67%64.98M
-92.88%2.31M
101.81%91.52M
64.16%74.57M
-2.39%58.72M
-46.04%32.44M
-38.19%45.35M
-44.94%45.42M
-31.37%60.15M
-27.60%60.12M
-33.55%73.37M
-27.34%82.50M
-35.40%87.64M
Operating profit
20.43%-36.15M
-9.94%-39.08M
-594.11%-44.33M
-121.79%-45.49M
25.50%-45.44M
48.41%-35.55M
80.04%-6.39M
40.63%-20.51M
2.96%-60.99M
-33.81%-68.91M
60.22%-32.01M
21.52%-34.54M
22.34%-62.84M
-30.21%-51.49M
-145.37%-80.45M
-82.14%-44.01M
51.65%-80.92M
-340.77%-39.55M
-197.24%-32.79M
-137.00%-24.16M
Net Profit
32.25%-38.33M
25.75%-37.64M
-230.49%-35.53M
2404.52%297.77M
-154.99%-56.57M
36.35%-50.70M
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
44.44%-96.08M
-571.00%-45.73M
-237.93%-38.53M
-150.65%-29.90M
Current assets
-33.57%206.03M
-39.49%206.71M
24.91%460.95M
-31.85%380.20M
-50.57%310.18M
-28.18%341.58M
-16.95%369.02M
44.74%557.93M
98.62%627.48M
24.76%475.63M
-0.87%444.37M
-13.72%385.48M
-38.35%315.93M
-36.71%381.23M
-33.40%448.27M
-32.31%446.78M
-16.98%512.44M
-21.52%602.32M
-7.41%673.04M
-2.34%660.01M
Total current liabilities
-48.11%132.33M
-50.39%140.39M
25.96%372.30M
-43.06%263.63M
-52.62%255.04M
-14.71%282.98M
23.33%295.57M
173.26%463.00M
336.20%538.30M
139.21%331.77M
39.89%239.66M
20.38%169.44M
-19.73%123.41M
-29.98%138.69M
-46.52%171.32M
-50.97%140.75M
-40.32%153.75M
23.11%198.07M
130.53%320.35M
108.90%287.05M
Total assets
-28.31%266.02M
-42.40%258.34M
2.28%516.52M
-34.88%439.46M
-51.40%371.07M
-28.76%448.53M
-13.50%505.00M
43.71%674.86M
89.74%763.54M
30.94%629.60M
5.97%583.78M
-13.99%469.59M
-32.18%402.43M
-29.22%480.85M
-25.73%550.91M
-26.17%546.00M
-14.41%593.39M
-19.29%679.33M
-7.71%741.73M
-2.26%739.54M
Total liabilities
-66.21%187.40M
-66.01%197.33M
-27.70%428.75M
-57.89%319.64M
-34.40%554.54M
-29.47%580.52M
-17.34%592.97M
17.79%758.96M
41.15%845.39M
33.12%823.03M
10.70%717.38M
13.32%644.36M
3.12%598.93M
6.30%618.26M
6.07%648.04M
-2.52%568.63M
2.69%580.82M
3.73%581.61M
11.49%610.97M
7.38%583.32M
Total equity
142.85%78.62M
146.23%61.01M
199.77%87.77M
242.47%119.83M
-124.17%-183.47M
31.76%-131.99M
34.15%-87.97M
51.87%-84.11M
58.35%-81.84M
-40.76%-193.43M
-37.54%-133.60M
-672.30%-174.76M
-1664.17%-196.51M
-240.62%-137.42M
-174.28%-97.13M
-114.49%-22.63M
-90.16%12.56M
-65.22%97.73M
-48.87%130.76M
-26.79%156.22M
Net operating income
-124.14%-57.89M
-168.92%-19.72M
25.28%-46.34M
-178.07%-46.63M
44.78%-25.83M
321.13%28.61M
-14.21%-62.02M
253.50%59.73M
31.96%-46.77M
87.06%-12.94M
-46.40%-54.30M
22.23%-38.91M
-27.18%-68.73M
-91.03%-99.95M
-370.51%-37.09M
-26515.43%-50.04M
-4053.55%-54.05M
-257.96%-52.32M
-71.05%13.71M
-100.31%-188.00K
Net investment
275.31%30.66M
-423.62%-2.84M
-15241.22%-67.23M
1572.83%462.64M
-108.62%-17.49M
-101.54%-542.00K
-99.12%444.00K
-33.14%27.66M
1056.93%202.76M
127.10%35.20M
11160.39%50.55M
4800.57%41.37M
149.21%17.53M
-220.85%-129.90M
-102.86%-457.00K
-103.73%-880.00K
87.52%-35.62M
-48.83%107.49M
-2.54%15.99M
109.86%23.59M
Net financing
20399.24%53.59M
3398.27%8.08M
101.20%2.00K
-49.81%-281.52M
-129.76%-264.00K
-36.89%231.00K
-101.50%-167.00K
-445.93%-187.93M
-76.68%887.00K
-94.45%366.00K
-77.28%11.11M
7434.67%54.33M
305.07%3.80M
343.38%6.59M
4338.42%48.87M
-98.46%721.00K
-176.06%-1.85M
-73.03%1.49M
-73.07%1.10M
-77.73%46.85M

FAQs

What is the total revenue of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its total revenue reached 42.17M, with a year-on-year change of 26.39M.

What are the current assets of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its current assets were 206.71M, with a year-on-year change of -39.49.

What are the total assets of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its total assets of Coherus BioSciences Inc were 258.34M, with a year-on-year change of -42.40.

What are the total liabilities of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its total liabilities of Coherus BioSciences Inc were 197.33M, with a year-on-year change of -66.01.

What is the total equity of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its total equity of Coherus BioSciences Inc was 61.01M, with a year-on-year change of 146.23.

What is the net operating income of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its net operating income of Coherus BioSciences Inc was -172.73M, with a year-on-year change of 7.21.

What is the net investment of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its net investment of Coherus BioSciences Inc was 375.09M, with a year-on-year change of 62.85.

What is the net financing of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its net financing of Coherus BioSciences Inc was -273.70M, with a year-on-year change of -46.39.

What is the Earnings Per Share (EPS) of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.43, with a year-on-year change of 476.39.

What is the net income of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its net income was 168.02M, with a year-on-year change of 489.41.

What is the net margin of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its net profit margin was -434.23, with a year-on-year change of 46.80.

What is the gross margin of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its gross margin was 67.24, with a year-on-year change of 0.47.

What is the debt-to-asset ratio of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its debt-to-asset ratio was 19.77, with a year-on-year change of -69.80.

What is the Return on Assets (ROA) of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -51.81, with a year-on-year change of -29.67.

What is the operating profit of Coherus BioSciences Inc?

According to Coherus BioSciences Inc's FY2025 earnings report, its operating profit was -172.73M, with a year-on-year change of 7.21.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.